Pharnext
Pharnext is a biopharmaceutical company engaged in the development of treatments for severe neurological diseases.
Total raised
€16M
€15,720,000
Funding rounds
3
Investors
2
distinct backers
Active since
2010-05
latest 2012-01
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood13
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood16
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
- ▲ 19y since founding
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2012-02-01 | Other | €8.0M | Truffle Capital | View deal → |
| 2011-09-01 | Other | €2.5M | Truffle Capital | View deal → |
| 2010-06-01 | Other | €5.2M | Aurinvest | View deal → |
Investors
2Similar companies
same sector or country- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Mistral AI€3.5BFrance · AI
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- ContentSquare€1.3BFrance · Software